Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2.
Macaluso FS, Cappello M, Giuffrida E, Fries W, Centritto A, Privitera AC, Inserra G, Vassallo R, Magnano A, Vinci E, Garufi S, Ventimiglia M, Renna S, Orlando R, Rizzuto G, Cottone M, Orlando A; Sicilian Network for Inflammatory Bowel Disease (SN-IBD).
Macaluso FS, et al. Among authors: inserra g.
Aliment Pharmacol Ther. 2019 Jan;49(2):234-236. doi: 10.1111/apt.15071.
Aliment Pharmacol Ther. 2019.
PMID: 30589969
No abstract available.